These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 35582568)

  • 1. Circulating non-coding RNAs in recurrent and metastatic ovarian cancer.
    Schwarzenbach H; Gahan PB
    Cancer Drug Resist; 2019; 2(3):399-418. PubMed ID: 35582568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.
    Shao Y; Li H; Du R; Meng J; Yang G
    J Cancer; 2018; 9(11):1966-1972. PubMed ID: 29896281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.
    Chen M; Lei N; Tian W; Li Y; Chang L
    Ther Adv Med Oncol; 2022; 14():17588359221118010. PubMed ID: 35983027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.
    Rezaee A; Ahmadpour S; Jafari A; Aghili S; Zadeh SST; Rajabi A; Raisi A; Hamblin MR; Mahjoubin-Tehran M; Derakhshan M
    Front Oncol; 2023; 13():1215194. PubMed ID: 37854681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
    Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
    Front Genet; 2021; 12():693259. PubMed ID: 34512721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-Coding RNAs Delivery by Small Extracellular Vesicles and Their Applications in Ovarian Cancer.
    Liu M; Zhou X; Tang J
    Front Bioeng Biotechnol; 2022; 10():876151. PubMed ID: 35662846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.
    Razavi ZS; Tajiknia V; Majidi S; Ghandali M; Mirzaei HR; Rahimian N; Hamblin MR; Mirzaei H
    Crit Rev Oncol Hematol; 2021 Jan; 157():103192. PubMed ID: 33290823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microRNAs in ovarian cancer.
    Kinose Y; Sawada K; Nakamura K; Kimura T
    Biomed Res Int; 2014; 2014():249393. PubMed ID: 25295252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer.
    Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y
    Front Oncol; 2021; 11():738945. PubMed ID: 34707990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs in the Glycolysis of Ovarian Cancer.
    Zhang C; Liu N
    Front Pharmacol; 2022; 13():855488. PubMed ID: 35431949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.
    Yeung TL; Leung CS; Yip KP; Au Yeung CL; Wong ST; Mok SC
    Am J Physiol Cell Physiol; 2015 Oct; 309(7):C444-56. PubMed ID: 26224579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.
    Nguyen VHL; Yue C; Du KY; Salem M; O'Brien J; Peng C
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tumor suppressor short non-coding RNAs on breast cancer.
    Salimimoghadam S; Taefehshokr S; Loveless R; Teng Y; Bertoli G; Taefehshokr N; Musaviaroo F; Hajiasgharzadeh K; Baradaran B
    Crit Rev Oncol Hematol; 2021 Feb; 158():103210. PubMed ID: 33385514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance.
    Li G; Gong J; Cao S; Wu Z; Cheng D; Zhu J; Huang X; Tang J; Yuan Y; Cai W; Zhang H
    Front Oncol; 2021; 11():742149. PubMed ID: 34660304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.